Skip to main content

Hepatopulmonary Syndrome clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Letrozole in Patients With Hepatopulmonary Syndrome

    open to eligible people ages 18-99

    The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.

    at UCSF

Last updated: